The Healius Ltd (ASX: HLS) share price is up 2.4% today after the former Primary Health Care told investors it expected net underlying profit after tax for FY 2019 to come in at the "lower end" of previous guidance between $93 million to $98 million.
According to the company this is in line with market consensus and it spruiked second half performance as being stronger than the first half with "positive lead indicators within the Medical Centres division". It declined to go as far as to provide guidance for FY 20 though.
Healius also flagged its CFO will leave the business after it hands in its FY 19 results this August, with the CEO of its pathology division following him out the door after 25 years' service. As yet it does not have replacements lined up.
The stock is down around 12% over the past year to $2.94 this lunchtime.
